Clinical trials
Phase 3 Pancreatic Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Revolution Medicines, Inc. | 3 |
| Arcus Biosciences, Inc. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Incyte Corporation | 1 |
| NantCell, Inc. | 1 |
| Orient Europharma Co., Ltd. | 1 |
| Royal Liverpool University Hospital | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| Taiho Pharmaceutical Co., Ltd. | 1 |
| Wakayama Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 12 |
| Endocrine Gland Neoplasms | 2 |
| Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Carcinoma, Pancreatic Ductal | 1 |
| Digestive System Diseases | 1 |
| Digestive System Neoplasms | 1 |
| Endocrine System Diseases | 1 |
| Jaundice | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.